Loring Wolcott & Coolidge Fiduciary Advisors’s Bausch Health BHC Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-500	Closed	-$13K	–	634
2016 Q1	$13K	Hold	500	–	–	﹤0.01%	515
2015 Q4	$51K	Buy	+500	New	+$56.2K	﹤0.01%	415
2014 Q3	–	Sell	-24	Closed	-$3K	–	592
2014 Q2	$3K	Sell	24 -16	-40%	-$2.04K	﹤0.01%	603
2014 Q1	$5K	Buy	+40	New	+$5.47K	﹤0.01%	580

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's BHC Position: Q2 2016 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 500 shares — an estimated $13K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in BHC in Q1 2014 and held it in 4 quarters. The position peaked at $51K in Q4 2015. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 500 Bausch Health shares in Q2 2016, an estimated $13K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Bausch Health in Q1 2014 and held it in 4 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Bausch Health position peaked at $51K in Q4 2015.
347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2016, filed 11 Jul 2016.